OtherJun 9, 2026, 06:06 AM
Starton Holdings Files for IPO of 5M Shares on Nasdaq
AI Summary
Starton Holdings, Inc. has filed an S-1/A, Amendment No. 4, for its initial public offering (IPO) of 5,000,000 shares of common stock, with an estimated price range of $5.00 to $7.00 per share. The company intends to list its shares on the Nasdaq Capital Market under the symbol "STA." The proceeds will primarily fund product development for its lead candidates, STAR-LLD-SC and STAR-LLD-OCR, which are continuous delivery systems for lenalidomide targeting hematologic malignancies, and for general working capital. Starton Holdings is a clinical-stage biotechnology company focused on improving cancer treatments through proprietary delivery technologies.
Key Highlights
- Starton Holdings, Inc. filed an S-1/A (Amendment No. 4) for an initial public offering of 5,000,000 shares of common stock.
- The estimated initial public offering price per share is between $5.00 and $7.00.
- The company has applied to list its common stock on the Nasdaq Capital Market under the symbol "STA."
- Proceeds from the offering are intended to support product development for STAR-LLD-SC and STAR-LLD-OCR, and for working capital.
- The company is a clinical-stage biotechnology company focused on improving cancer therapies through continuous drug delivery technology.
- Lead development programs include STAR-LLD, a continuous delivery system for lenalidomide, targeting multiple myeloma and chronic lymphocytic leukemia.
- Starton Holdings, Inc. is classified as an emerging growth company and a smaller reporting company.